E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/18/2015 in the Prospect News PIPE Daily.

Nephros gives details on $1.23 million private placement of units

Company sells 1.83 million units of one share, one half-share warrant

By Toni Weeks

San Luis Obispo, Calif., May 18 – Nephros, Inc. gave more details about its private placement of units, in which it will raise about $1.23 million. The deal priced on May 12.

The company is selling 1,834,299 units of one common share and a half-share warrant at $0.67 per unit.

Each whole five-year warrant is exercisable at $0.85. The strike price is a 13.33% premium to the May 11 closing share price of $0.75.

Settlement will occur by May 19.

Director Matthew Rosenberg invested $134,000, and the spouse of Malcolm Persen invested $20,877, according to an 8-K filing with the Securities and Exchange Commission.

Nephros is a New York-based medical device company.

Issuer:Nephros, Inc.
Issue:Units of one common share and one half-share warrant
Amount:$1,228,980
Shares:1,834,299
Price:$0.67
Warrants:One half-share warrant per unit
Warrant expiration:Five years
Warrant strike price:$0.85
Investors:Matthew Rosenberg (for $134,000), spouse of Malcolm Persen (for $20,877)
Pricing date:May 12
Settlement date:May 19
Stock symbol:OTCBB: NEPH
Stock price:$0.75 at close May 11
Market capitalization:$22.69 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.